Search

everythinglearnresearchcommunity

for

Search:↓

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

CRISPR/Cas9 gene-editing shows promise for improving sheep and goat breeding but faces challenges with efficiency and accuracy.

Skin problems like excessive hair growth, acne, and dark skin patches can be signs of Polycystic Ovarian Disease, which may also be linked to family history and a risk for diabetes.

Male-pattern baldness has a weak link to heart disease and some related health conditions.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

Skin issues can indicate immune system problems.

A patient with a larger than usual genetic mutation had a broader range of symptoms for a muscle disease.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Notch signaling disruptions can cause various skin diseases.

Gene therapy, especially using atoh1, shows promise for creating functional sensory hair cells in the inner ear, but dosing and side effects need to be managed for clinical application.

Balding people may have higher heart disease risk.

The document concludes that systemic autoimmune diseases are complex, incurable, and require ongoing treatment and research.

Two siblings with a genetic mutation had a form of rickets that doesn't respond to vitamin D.

A specific genetic change is linked to mental disorders, intellectual disability, and possibly autoimmune disease in a family.

An 8-year-old boy with Recklinghausen's Disease shows various symptoms and is from a family with close genetic ties.

All medications can cause skin rashes, often without a clear cause, and better tests are needed to identify these drug-related skin issues.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

A patient with Wilson's disease showed hair-pulling behavior as an initial symptom.

Mitochondrial dysfunction links metabolic syndrome and inflammatory skin diseases, suggesting targeted therapies and lifestyle changes.

Polycystic ovarian disease symptoms can continue after menopause, making diagnosis and management in older women challenging.

Six new risk spots for early hair loss were found, which also link to Parkinson's disease and lower fertility. Two genes, FOXA2 and HDAC4, could be new treatment targets. Hair loss might also be connected to heart disease, metabolic syndrome, and prostate cancer.

K_ATP channel gene mutations are linked to heart diseases, but more research is needed to understand the connection and treatment potential.

Acne is a chronic disease linked to various systemic conditions and has significant psychological and social effects.

Keratin 17 is linked to various diseases, including cancer and skin conditions, and may be a target for diagnosis and treatment.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

Older adults commonly experience hair loss and nail disorders due to aging and health changes, affecting their quality of life.

Certain proteins involved in DNA modification may affect the genetic changes in systemic lupus erythematosus and could indicate the disease's activity.

Alopecia areata is an autoimmune condition causing patchy hair loss, with treatments focusing on immune system regulation and hair regrowth.